US 10391170
Stable anti-OSMR antibody formulation
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 10391170 (Stable anti-OSMR antibody formulation) held by Kiniksa Pharmaceuticals, GmbH expires Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kiniksa Pharmaceuticals, GmbH
- Grant date
- Tue Aug 27 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 22 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61K39/3955, A61P